Here are relevant reports on : drug-discovery-market
-
Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Europe Proteomics market, valued at USD9.80 billion in 2024, stood at USD10.55 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of USD18.77 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Protein Microarrays Market by Offering (Products, Services), Type (Biochips, Microarray Instruments), Application (Clinical, Drug Discovery) - Global Forecast to 2030
The global protein microarrays market, valued at US$0.93 billion in 2024, stood at US$1.00 billion in 2025 and is projected to advance at a resilient CAGR of 12.3% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Chromatography Resin Market in Drug Discovery by Type (Natural, Synthetic, Inorganic Media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal), and Region - Global Forecast to 2022
MarketsandMarkets projects that the market for chromatography resin in drug discovery will grow from USD 290.7 Million in 2017 to USD 401.1 Million by 2022, at a CAGR of 6.65% from 2017 to 2022. The growth of this market is expected to be driven by the rising demand from pharmaceuticals and biotechnology verticals. Companies such as General Electric Company (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Tosoh Corporation (Japan) were the key players who adopted these strategies to increase their customer base and widen their product portfolio.
- Published: June 2017
- Price: $ 4950
- TOC Available:
-
Microplate Systems Market by Product (Microplate Reader (Multi-mode, Single-mode), Microplate Washer, Microplate Accessories), Application (Drug Discovery, Clinical Diagnostics) & End User (Hospital and Diagnostic Laboratories) - Global Forecast to 2026
The global microplate systems market in terms of revenue was estimated to be worth $927 million by 2021 and is poised to reach $1,170 million by 2026, growing at a CAGR of 4.8% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Drug Discovery Technologies Market by Product (Instruments, Reagents, Software), Technology (HTS, NGS, PCR, AI-based, Lab-on-chip), Process (Target Identification, Validation, Lead Optimization), Therapeutic Area (Oncology, CVD) - Global Forecast to 2030
The Drug Discovery Technologies market, valued at US$28.61 billion in 2024, stood at US$30.58 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$51.51 billion by the end of the period. The growth of the drug discovery technologies market is driven by the broader use of advanced screening platforms and rising demand for biologics, cell and gene therapies, and RNA-based drugs.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Genomics Market by Offering (Software & Services), Technology (Machine Learning), Functionality (Gene Sequencing, Gene Editing), Application (Diagnostics, Drug discovery), End User (Pharma, Hospitals) - Global Forecast to 2028
The global artificial intelligence in genomics market, valued at US$0.4 billion in 2022, stood at US$0.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2028, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The growth in this market is predominantly driven by the need to accelerate processes and timelines, reduce costs of drug development and discovery, and improve computing power through declining hardware costs.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region - Global Forecast to 2030
The global quantum computing in healthcare market, valued at US$191.3 million in 2024, stood at US$265.9 million in 2025 and is projected to advance at a resilient CAGR of 37.9% from 2025 to 2030, culminating in a forecasted valuation of US$1324.2 million by the end of the period. The quantum computing in healthcare market is rapidly growing, driven by the need for faster and more advanced data analysis in areas like drug discovery, genomics, and precision medicine.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
Global high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
South Korea Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing (Consumables), Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031
The South Korea next-generation sequencing market, valued at USD 0.19 billion in 2025, stood at USD 0.20 billion in 2026 and is projected to advance at a resilient CAGR of 14.0% from 2026 to 2031, culminating in a forecasted valuation of USD 0.39 billion by the end of the period. The report profiles key players such as Illumina Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), PacBio (US), and Oxford Nanopore Technologies plc. (UK).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Liquid Handling System Market by Type (Automated, Electronic, Manual), Product (Pipettes, Consumables, Accessories, Software), Application (Drug Discovery, Genomics, Diagnostics, Proteomics, Food, Forensic, Environmental), End User, Region - Global Forecasts to 2030
The global liquid handling systems market, valued at US$4.7B in 2024, is forecasted to grow at a 8.0% CAGR, reaching US$ 5.1B by 2025 and US$7.4B by 2030. The increasing trend of outsourcing pharmaceutical research enables businesses to cut costs and obtain specialty expertise. Rising investments in life sciences research and development are helping fuel innovation across the drug discovery and development process.
- Published: May 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
